Greater Anxiety Linked With Unmet Information Needs in Precancerous Oral Lesions
the Cancer Therapy Advisor take:
Greater anxiety levels were associated with high degrees of unmet information need in patients with precancerous oral lesions, according to an article published online in the European Journal of Cancer Care.
Participants in this study included 106 individuals seen at the otolaryngology outpatient department at a single medical center in central Taiwan for precancerous oral lesions. The patients completed structured questionnaires that aimed to measure their state anxiety levels, attitudes towards cancer prevention, and need for information.
Results showed the most common unmet information needs among the patients were about obtaining their test results promptly.
Furthermore, higher levels of unmet information needs were more common in patients with precancerous oral lesions who reported high levels of state anxiety, had a long duration of time since quitting betel nut chewing, and had no history of oral cancer.
Patients with unmet information needs were more likely to have higher levels of anxiety about precancerous lesions than those who had their information needs met.
The study suggests improvements be made in health education and individual counseling in order to satisfy information needs of patients.
Greater anxiety levels were associated with high degrees of unmet information need in patients with precancerous oral lesions.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Breast Implant-Associated Anaplastic Large Cell Lymphoma — In the Clinic
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Larotrectinib: Promising for All TRK-Positive Tumors
- 5α-Reductase Inhibitors Do Not Increase Risk of High-Grade Prostate Cancer
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy
- Modified XELIRI Yields Similar Outcomes to FOLFIRI in Metastatic CRC
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- NSCLC: Stratifying Patients With Complex EGFR Mutations